Paul Tudor Jones Edgewise Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 43,809 shares of EWTX stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,809
Previous 35,613
23.01%
Holding current value
$1.03 Million
Previous $950,000
23.05%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.4MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$355 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$210 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$145 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$142 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$118 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.49B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...